Another Fatal Blood Clotting Disorder Linked To AstraZeneca’s Covid Vaccine
The business has also voluntarily withdrawn its COVID-19 vaccine's marketing authorization from Europe and other global markets
AstraZeneca Acknowledges Its ‘Covishield’ COVID-19 Vaccine Side Effects
Covishield, which was developed by AstraZeneca and Oxford University during the pandemic, was manufactured by the Serum Institute of India
